Differential regulation of protein synthesis in skeletal muscle and liver of neonatal pigs by leucine through an mTORC1-dependent pathway
10 pages
English

Découvre YouScribe en t'inscrivant gratuitement

Je m'inscris

Differential regulation of protein synthesis in skeletal muscle and liver of neonatal pigs by leucine through an mTORC1-dependent pathway

-

Découvre YouScribe en t'inscrivant gratuitement

Je m'inscris
Obtenez un accès à la bibliothèque pour le consulter en ligne
En savoir plus
10 pages
English
Obtenez un accès à la bibliothèque pour le consulter en ligne
En savoir plus

Description

Neonatal growth is characterized by a high protein synthesis rate that is largely due to an enhanced sensitivity to the postprandial rise in insulin and amino acids, especially leucine. The mechanism of leucine's action in vivo is not well understood. In this study, we investigated the effect of leucine infusion on protein synthesis in skeletal muscle and liver of neonatal pigs. To evaluate the mode of action of leucine, we used rapamycin, an inhibitor of mammalian target of rapamycin (mTOR) complex-1 (mTORC1). Overnight-fasted 7-day-old piglets were treated with rapamycin for 1 hour and then infused with leucine (400 μmol·kg -1 ·h -1 ) for 1 hour. Leucine infusion increased the rate of protein synthesis, and ribosomal protein S6 kinase 1 (S6K1) and eukaryotic initiation factor (eIF) 4E-binding protein-1 (4E-BP1) phosphorylation in gastrocnemius and masseter muscles ( P < 0.05), but not in the liver. The leucine-induced stimulation of protein synthesis and S6K1 and 4E-BP1 phosphorylation were completely blocked by rapamycin, suggesting that leucine action is by an mTORC1-dependent mechanism. Neither leucine nor rapamycin had any effect on the activation of the upstream mTORC1 regulators, AMP-activated protein kinase and protein kinase B, in skeletal muscle or liver. The activation of eIF2α and elongation factor 2 was not affected by leucine or rapamycin, indicating that these two pathways are not limiting steps of leucine-induced protein synthesis. These results suggest that leucine stimulates muscle protein synthesis in neonatal pigs by inducing the activation of mTORC1 and its downstream pathway leading to mRNA translation.

Sujets

Informations

Publié par
Publié le 01 janvier 2012
Nombre de lectures 7
Langue English

Extrait

Suryawanet al.Journal of Animal Science and Biotechnology2012,3:3 http://www.jasbsci.com/content/3/1/3
R E S E A R C H
JOURNAL OF ANIMAL SCIENCE AND BIOTECHNOLOGY
Open Access
Differential regulation of protein synthesis in skeletal muscle and liver of neonatal pigs by leucine through an mTORC1dependent pathway * Agus Suryawan, Hanh V Nguyen, Rosemarie D Almonaci and Teresa A Davis
Abstract Neonatal growth is characterized by a high protein synthesis rate that is largely due to an enhanced sensitivity to the postprandial rise in insulin and amino acids, especially leucine. The mechanism of leucines actionin vivois not well understood. In this study, we investigated the effect of leucine infusion on protein synthesis in skeletal muscle and liver of neonatal pigs. To evaluate the mode of action of leucine, we used rapamycin, an inhibitor of mammalian target of rapamycin (mTOR) complex1 (mTORC1). Overnightfasted 7dayold piglets were treated with 1 1 rapamycin for 1 hour and then infused with leucine (400μmol∙kg ∙h ) for 1 hour. Leucine infusion increased the rate of protein synthesis, and ribosomal protein S6 kinase 1 (S6K1) and eukaryotic initiation factor (eIF) 4Ebinding protein1 (4EBP1) phosphorylation in gastrocnemius and masseter muscles (P< 0.05), but not in the liver. The leucineinduced stimulation of protein synthesis and S6K1 and 4EBP1 phosphorylation were completely blocked by rapamycin, suggesting that leucine action is by an mTORC1dependent mechanism. Neither leucine nor rapamycin had any effect on the activation of the upstream mTORC1 regulators, AMPactivated protein kinase and protein kinase B, in skeletal muscle or liver. The activation of eIF2aand elongation factor 2 was not affected by leucine or rapamycin, indicating that these two pathways are not limiting steps of leucineinduced protein synthesis. These results suggest that leucine stimulates muscle protein synthesis in neonatal pigs by inducing the activation of mTORC1 and its downstream pathway leading to mRNA translation. Keywords:leucine, mTORC1, neonatal pigs, rapamycin, skeletal muscle
Introduction One of the hallmarks of the neonatal period is rapid growth, which is due to a high rate of protein synthesis [1]. We previously showed in neonatal pigs that the high rate of deposition of proteins, especially in skeletal muscle, is in part due to their ability to increase protein synthesis in response to feeding, a response that significantly declines with development [2]. We further demonstrated that the feedinginduced stimulation of protein synthesis in most tissues is independently regulated by insulin and amino acids [3]. Among amino acids, we found that leu cine alone can stimulate protein synthesis in neonatal pigs and this effect decreases with development [4,5]. However, the molecular mechanism underlying the effect of leucine
* Correspondence: tdavis@bcm.edu Department of Pediatrics, Baylor College of Medicine, United States Department of Agriculture/Agriculture Research Service Childrens Nutrition Research Center, 1100 Bates Street, Houston, TX 77030, USA
on the stimulation of protein synthesisin vivois not com pletely known. Mammalian target of rapamycin (mTOR) is a nutri ent and hormonesensitive kinase that plays a major role in cell metabolism, including protein synthesis [6,7]. The kinase mTOR exists in two structurally and func tionally distinct complexes referred to as mTOR com plex 1 (mTORC1) and mTORC2 [6]. Considerable evidence indicates that mTORC1 is rapamycin sensitive while mTORC2 is rapamycin insensitive. The main function of mTORC1 is to regulate mRNA translation by directly phosphorylating two downstream substrates, ribosomal protein S6 kinase 1 (S6K1) and eukaryotic initiation factor (eIF) 4Ebinding protein1 (4EBP1). S6K1 is a kinase for ribosomal protein S6 (rpS6) and its activation by S6K1 is crucial for mRNA translation. Furthermore, a phosphorylated form of 4EBP1 releases eIF4E from the inactive eIF4E∙4EBP1 complex, allowing
© 2012 Suryawan et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
  • Univers Univers
  • Ebooks Ebooks
  • Livres audio Livres audio
  • Presse Presse
  • Podcasts Podcasts
  • BD BD
  • Documents Documents